Preferred Label : Behr syndrome;
Symbol : BEHRS;
CISMeF acronym : BEHRS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Optic atrophy, infantile hereditary, with neurologic abnormalities;
Description : 'Behr syndrome' is a clinical term that refers to the constellation of early-onset
optic atrophy accompanied by neurologic features, including ataxia, pyramidal signs,
spasticity, and mental retardation (Behr, 1909; Thomas et al., 1984). Type III 3-methylglutaconic
aciduria (258501) shows a very similar clinical phenotype, with the addition of increased
urinary 3-methyglutaconic acid. It is most common in individuals of Iraqi Jewish origin.
However, Lerman-Sagie (1995) noted that this abnormal urinary pattern may not be picked
up by routine organic acid analysis, suggesting that early reports of Behr syndrome
with normal metabolic features may have actually been 3-methyglutaconic aciduria type
III.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the OPA1 mitochondrial dynamin-like GTPase gene (OPA1, 605290.0003);
Laboratory abnormalities : Increased lactate in the cerebrospinal fluid; Reduced mitochondrial complex I activity in fibroblasts;
Prefixed ID : #210000;
Origin ID : 210000;
UMLS CUI : C0221061;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)